National Health Spending By Medical Condition, 1996–2005

Roehrig, Charles; Miller, George; Lake, Craig; Bryant, Jenny

doi:10.1377/hlthaff.28.2.w358

Cited by 110 publications

(78 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…As a result, the costs attributable to obesity are almost entirely a result of costs generated from treating the diseases that obesity promotes. For example, Charles Roehrig and colleagues 14 show that annual medical costs for people with diabetes total $190.5 billion. Although not all of these costs are attributable to obesity, excess weight is the single greatest predictor of developing diabetes.…”

Section: Discussionmentioning

confidence: 99%

Annual Medical Spending Attributable To Obesity: Payer-And Service-Specific Estimates

et al. 2009

View full text Add to dashboard Cite

Amid calls for health reform, real cost savings are more likely to be achieved through reducing obesity and related risk factors.by Eric A. Finkelstein, Justin G. Trogdon, Joel W. Cohen, and William Dietz ABSTRACT: In 1998 the medical costs of obesity were estimated to be as high as $78.5 billion, with roughly half financed by Medicare and Medicaid. This analysis presents updated estimates of the costs of obesity for the United States across payers (Medicare, Medicaid, and private insurers), in separate categories for inpatient, non-inpatient, and prescription drug spending. We found that the increased prevalence of obesity is responsible for almost $40 billion of increased medical spending through 2006, including $7 billion in Medicare prescription drug costs. We estimate that the medical costs of obesity could have risen to $147 billion per year by 2008. [Health Affairs 28, no. 5 (2009): w822-w831

show abstract

Section: Discussionmentioning

confidence: 99%

Annual Medical Spending Attributable To Obesity: Payer-And Service-Specific Estimates

et al. 2009

View full text Add to dashboard Cite

show abstract

“…4 In the past decade, the medical costs of CVD have grown at an average annual rate of 6% and have accounted for Ϸ15% of the increase in medical spending. 5 The growth in costs has been accompanied by greater life expectancy, suggesting that this spending was of value. 6 Despite this trend, there are many opportunities to further improve cardiovascular health while controlling costs.…”

mentioning

confidence: 99%

Forecasting the Future of Cardiovascular Disease in the United States

Heidenreich¹,

Trogdon²,

Khavjou³

et al. 2011

Circulation

2,802

1,750

View full text Add to dashboard Cite

Background-Cardiovascular disease (CVD) is the leading cause of death in the United States and is responsible for 17%of national health expenditures. As the population ages, these costs are expected to increase substantially. Methods and Results-To prepare for future cardiovascular care needs, the American Heart Association developed methodology to project future costs of care for hypertension, coronary heart disease, heart failure, stroke, and all other

show abstract

“…For example, Roehrig et al (45) theorized that the 19% growth in spending on hyperlipidemia treatment between 1996 and 2005 (which captures only the cost of treating hyperlipidemia, not spending attributable to hyperlipidemia or total spending for individuals with hyperlipidemia) was due partially to the rise in clinical incidence but also to the diffusion of new cholesterol treatments and changes in the clinical threshold for treatment. Likewise, they hypothesized that the relatively slow growth in diabetes spending over the same time period may reflect the advent of more effective treatments, which reduced the occurrence of highcost events or complications (45).…”

Section: Evidence Of Treated Prevalence and Spending Per Case Treatedmentioning

confidence: 99%

The Medicalization of Chronic Disease and Costs

Thorpe

Philyaw

2012

Annu. Rev. Public Health

View full text Add to dashboard Cite

U.S. health care spending has increased dramatically in the past several decades, consuming 17.6% percent ($2.6 trillion) of GDP in 2010. Although historical spending drivers do not account for this recent increase, two major changes in population health-the rise in obesity and obesity-related chronic disease-provide a likely explanation. This article reviews the contribution that rising treated obesity-related chronic disease prevalence and its associated treatment (spending per treated case) has made to the growth in health care spending. We discuss trends in the clinical incidence of obesity and chronic disease as well as timely advancements in disease detection, treatment, and management. Evidence shows that rising obesity rates are influencing spending largely by increasing the treated prevalence of obesity-related chronic disease. Therefore, preventing individuals from becoming treated cases in the first place is one key way that our country can cut health care spending moving forward.

show abstract

National Health Spending By Medical Condition, 1996–2005

Cited by 110 publications

References 6 publications

Annual Medical Spending Attributable To Obesity: Payer-And Service-Specific Estimates

Annual Medical Spending Attributable To Obesity: Payer-And Service-Specific Estimates

Forecasting the Future of Cardiovascular Disease in the United States

The Medicalization of Chronic Disease and Costs

Contact Info

Product

Resources

About